DYNAVAX TECHNOLOGIES CORP's ticker is and the CUSIP is 268158AD4. A total of 16 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $609,240 | +8.8% | 400,000 | 0.0% | 0.00% | – |
| Q2 2023 | $560,000 | -41.4% | 400,000 | -50.0% | 0.00% | – |
| Q1 2023 | $956,000 | +90.1% | 800,000 | +100.0% | 0.00% | – |
| Q4 2022 | $503,000 | -0.2% | 400,000 | 0.0% | 0.00% | – |
| Q3 2022 | $504,000 | -13.4% | 400,000 | 0.0% | 0.00% | – |
| Q2 2022 | $582,000 | – | 400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 52,942,000 | $67,068,000 | 0.61% |
| Skaana Management L.P. | 1,400,000 | $1,765,000 | 0.61% |
| III Capital Management | 4,000,000 | $5,063,000 | 0.49% |
| Graham Capital Management, L.P. | 8,000,000 | $10,128,000 | 0.40% |
| DeepCurrents Investment Group LLC | 6,500,000 | $8,227,000 | 0.32% |
| CSS LLC/IL | 5,000,000 | $6,326,000 | 0.30% |
| PFM Health Sciences, LP | 5,000,000 | $6,328,000 | 0.23% |
| LAZARD ASSET MANAGEMENT LLC | 44,250,000 | $55,998,000 | 0.08% |
| Verition Fund Management LLC | 3,846,000 | $2,436,434 | 0.03% |
| Citadel Advisors | 67,735,000 | $85,790,000 | 0.02% |